Literature DB >> 15752082

Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report.

A M Contucci1, R Inzitari, S Agostino, A Vitali, A Fiorita, T Cabras, E Scarano, I Messana.   

Abstract

OBJECTIVE: The aim of this study was to measure concentration of human salivary statherin in patients with oral cavity pathologies and salivary gland diseases. SUBJECTS AND METHODS: Levels of statherin were analysed with High Performance Liquid Chromatography (HPLC) in following groups of subjects: group A: 24 patients with neoplastic diseases of salivary glands, group B: 13 patients with inflammatory lesions of salivary glands, group C: 13 patients with precancerous and cancerous lesions of the oral cavity excluding salivary gland tumors, group D: 20 healthy volunteers (control group).
RESULTS: Our preliminary data indicated a sensible reduction of the statherin level in the saliva of patients with precancerous and cancerous lesions of the oral cavity (group C) compared with the healthy subjects (group D). The statherin levels are not significantly reduced either in the inflammatory (group B) or in the salivary glands tumours (group A), compared with the healthy subjects (group D).
CONCLUSION: Statherin could play a protective effect in oral cavity in association with its other functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752082     DOI: 10.1111/j.1601-0825.2004.01057.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  9 in total

Review 1.  Saliva diagnostics - Current views and directions.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Carmen Martin Carreras-Presas; Katri Aro; Michael Tu; Franklin Garcia-Godoy; David Tw Wong
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-08

Review 2.  Proteomics of saliva: personal experience.

Authors:  E Scarano; A Fiorita; P M Picciotti; G C Passali; L Calò; T Cabras; R Inzitari; C Fanali; I Messana; M Castagnola; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-06       Impact factor: 2.124

3.  Electron microscopic detection of statherin in secretory granules of human major salivary glands.

Authors:  M Isola; T Cabras; R Inzitari; M S Lantini; E Proto; M Cossu; A Riva
Journal:  J Anat       Date:  2008-04-08       Impact factor: 2.610

Review 4.  Potential applications of human saliva as diagnostic fluid.

Authors:  M Castagnola; P M Picciotti; I Messana; C Fanali; A Fiorita; T Cabras; L Calò; E Pisano; G C Passali; F Iavarone; G Paludetti; E Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-12       Impact factor: 2.124

5.  A review of research on salivary biomarkers for oral cancer detection.

Authors:  Yi-Shing Lisa Cheng; Terry Rees; John Wright
Journal:  Clin Transl Med       Date:  2014-02-24

6.  Secretion of salivary statherin is compromised in uncontrolled diabetic patients.

Authors:  Masahiro Izumi; Bin-Xian Zhang; David D Dean; Alan L Lin; Michèle J Saunders; Helen P Hazuda; Chih-Ko Yeh
Journal:  BBA Clin       Date:  2015-06-01

7.  Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.

Authors:  Éva Csősz; Péter Lábiscsák; Gergő Kalló; Bernadett Márkus; Miklós Emri; Adrienn Szabó; Ildikó Tar; József Tőzsér; Csongor Kiss; Ildikó Márton
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

8.  Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma.

Authors:  Qiqi Wu; Ruoyan Cao; Juan Chen; Xiaoli Xie
Journal:  Exp Ther Med       Date:  2019-09-11       Impact factor: 2.447

9.  Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.

Authors:  Kayo Inoue; Hiroshi Tsubamoto; Roze Isono-Nakata; Kazuko Sakata; Nami Nakagomi
Journal:  BMC Cancer       Date:  2018-06-04       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.